ABSI - Absci to Participate in Upcoming Investor Conferences | Benzinga

VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI), a generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences.

• H.C. Wainwright 25^th Annual Global Investment Conference
  Fireside chat on Monday, September 11^th at 2:00 p.m. Eastern Time

• Morgan Stanley 21^st Annual Global Healthcare Conference
  Fireside chat on Wednesday, September 13^th at 4:55 p.m. Eastern Time

• 2023 Cantor Fitzgerald Global Healthcare Conference
  Fireside chat on Tuesday, September 26^th at 8:10 a.m. Eastern Time

Interested parties may access live and archived webcasts of these events on the company's investor relations website at: investors.absci.com.

About Absci

Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies ...

Full story available on Benzinga.com